ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Top Neurology Prescribers in Pennsylvania

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DAVID TABBY DO

Neurology

10,538

$3.82M

552
167 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$362
Average prescription price

Avg: $278

SUSAN BASER MD

Neurology

10,475

$1.82M

845
680 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$174
Average prescription price

Avg: $278

MICHAEL SAUTER M.D.

Neurology

8,389

$1.68M

884
597 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

2%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$201
Average prescription price

Avg: $278

CARLOS MARRERO MD

Neurology

7,888

$1.08M

372
156 are 65+

28%
patients receiving schedule two controlled substances

Avg: 3%

39%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 25%

$137
Average prescription price

Avg: $278

KUSSAY NASSR MD

Neurology

7,780

$808K

658
294 are 65+

83%
patients receiving schedule two controlled substances

Avg: 3%

21%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$104
Average prescription price

Avg: $278

HYUNG YEO MD

Neurology

7,666

$474K

384
94 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 25%

$62
Average prescription price

Avg: $278

JAMES VALERIANO MD

Neurology

7,105

$1.61M

405
144 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 25%

$227
Average prescription price

Avg: $278

VITHALBHAI DHADUK M.D.

Neurology

6,926

$1M

762
459 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$145
Average prescription price

Avg: $278

JOHN CAREY M.D.

Neurology

6,179

$1.32M

737
497 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$213
Average prescription price

Avg: $278

JOHN PARRY M.D.

Neurology

5,940

$1.1M

583
383 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$185
Average prescription price

Avg: $278

MAHMOOD NASIR MD

Neurology

5,846

$379K

322
29 are 65+

84%
patients receiving schedule two controlled substances

Avg: 3%

24%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $278

THOMAS SCOTT MD

Neurology

5,380

$6.54M

350
106 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 25%

$1216
Average prescription price

Avg: $278

LOUIS CATALANO MD

Neurology

5,270

$1.46M

519
313 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 2%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$278
Average prescription price

Avg: $278

RASIK PARMAR MD

Neurology

5,180

$486K

384
215 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 25%

$94
Average prescription price

Avg: $278

KORNEL LUKACS MD

Neurology

5,103

$498K

159
28 are 65+

23%
patients receiving schedule two controlled substances

Avg: 3%

60%
patients receiving schedule three controlled substances

Avg: 2%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 25%

$98
Average prescription price

Avg: $278

BRUCE COTUGNO M.D.

Neurology

5,078

$859K

416
272 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$169
Average prescription price

Avg: $278

E. ROY M.D.

Neurology

4,804

$1.03M

322
168 are 65+

10%
patients receiving schedule two controlled substances

Avg: 3%

15%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$215
Average prescription price

Avg: $278

ELLIOT MICHEL M.D.

Neurology

4,700

$1.98M

366
189 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$422
Average prescription price

Avg: $278

STEVEN GELFAND MD

Neurology

4,566

$806K

412
237 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$177
Average prescription price

Avg: $278

MARINA ZARETSKAYA M.D.

Neurology

4,524

$809K

438
284 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$179
Average prescription price

Avg: $278

BETH COHEN M.D.

Neurology

4,441

$779K

208
78 are 65+

46%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$175
Average prescription price

Avg: $278

NARENDRA DHADUK MD MPH FAAN

Neurology

4,276

$700K

386
312 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$164
Average prescription price

Avg: $278

MOHAMMAD ASLAM MD

Neurology

4,273

$397K

260
105 are 65+

20%
patients receiving schedule two controlled substances

Avg: 3%

22%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$93
Average prescription price

Avg: $278

FUHAI LI M.D.

Neurology

4,236

$673K

236
53 are 65+

84%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 25%

$159
Average prescription price

Avg: $278

JOSEPH CLARK M.D.

Neurology

4,156

$1.26M

511
277 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 25%

$302
Average prescription price

Avg: $278

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank